PressureDOTThe pioneer of telemedicine
Creating a new digital medical ecosystem. This product serves as a gateway to digital healthcare and is specifically designed for patients with abdominal compartment syndrome. According to research, the IAP testing market is expected to grow at a CAGR of 5.4% in the United States., This innovative detection method is expected to generate profits of up to 1.2 billion US dollars in the future.。In the future, we will combine the electronics industry and medical IoT to expand our industry collaborations.
A new industry ecosystem of cross-border innovation.Creating mutual benefit
Dotspace Inc. is committed to optimizing existing medical service processes and actively incorporating new industrial technologies, with the aim of creating a new paradigm shift in health, medical, and care in the future.
Our services
We are doing a couple of things you might be interested in
Health
Medical
Care
Monitoring capsules significantly reduce diagnostic errors!
A collaboration between surgeons from Medical center and a previous senior medical device R&D engineer from Google.Through precise pressure sensing and wireless signal transmission for accurate data
the smallest smart capsule in the world
The smallest in vivomonitoring system
The volume reduction compared to competing products
-
AEA Innovation Award
-
The 17th National
Innovation Award
PressureDot Abdominal pressure
monitoring capsule
Clinical intra-abdominal
pressure measurement
Operating method
Disposable oral capsule
144 hours automatic continuous monitoring of intra-abdominal pressure in real-time
Inserting sterile saline into the bladder through the urethra, and measuring the bladder pressure every 4-6 hours on a manually scheduled basis to obtain the value, which is not real-time.
Healthcare personnel
requirements
No human intervention is needed unless there is an abnormal alert.
Compared to the intra-abdominal pressure monitoring capsule, it requires up to 30 times more manpower.
Risk assessment
The probability is extremely low
the pressure monitoring capsule will be excreted from the body within a week (unless the patient has intestinal obstruction that causes delayed excretion of the capsule).
Moderate risk ; the sterile environment of the bladder is compromised with each measurement.
Mortality rate due to
intra-abdominal hypertension
5%
50%
Future Plan
Continuously optimizing and extending product advantages, expanding collaborations with other industries.
Our services
We are doing a couple of things you might be interested in
Short-term
Introduce new product to the market and promote widespread adoption
- Apply for and utilize insurance reimbursement for sales
- Establish consignment sales channels and actively enter the medical supply chain
Mid-term
Actively develop and expand the supplier network
- Establish a system platform for authorized revenue sharing
- Expand to medical IT system suppliers
Long-term
Further explore demand and cooperate with new industries
- Plan solutions for the whole-person health check market
- Expand remote monitoring and IT services
- License product technology internationally.